Our research

Detect Early. Treat better. Save lives.

Decades of underfunding mean that we still lack the tests and treatments to tackle this brutal disease. Hope alone can’t fix this. People with pancreatic cancer need action now.

That’s why our research strategy is vitally important. It aims to transform the future for people with pancreatic cancer. From cutting-edge tests to cancer-killing therapies, our scientists are striving for earlier detection and better treatment.

We’re also investing in the brightest minds, to grow the research community and accelerate the life-saving breakthroughs that we so urgently need.

Early detection

Late diagnosis is one of the biggest issues in pancreatic cancer but we’re investing in ground-breaking research to change this.

Find out more
Scientist pipetting with hands in a laboratory

Improving treatment and care

As well as investing in research to save lives, we’re also working to transform people’s experience of pancreatic cancer, funding new approaches and encouraging innovative thinking.

Find out more
Hospital appointment
Two researchers working together in a lab wearing their white lab coats

Our research strategy

Our strategy lays out how we will work with world leading researchers and with people affected by pancreatic cancer, to fund research that will transform and save lives.

Find out more
survival rate of pancreatic cancer

Building research capacity

Researchers will find the breakthroughs needed in pancreatic cancer, so we must do everything we can to build and support the community.

Find out more

Are you a researcher?

Find out more about opportunities for funding and support for the pancreatic cancer research community. Together we are the research community taking pancreatic cancer on.

Read more
  • Thank you for another fantastic November

    Thank you for another fantastic November

    Celebrating another successful Pancreatic Cancer Awareness Month

  • Seven in ten pancreatic cancer patients taking desperate measures to cope with PERT shortages

    Seven in ten pancreatic cancer patients taking desperate measures to cope with PERT shortages

    We asked our supporters how they are dealing with medicine shortages and uncovered that seven in ten people with pancreatic cancer are taking desperat...

  • Our position on the Terminally Ill Adults (End of Life) Bill

    Our position on the Terminally Ill Adults (End of Life) Bill

    The Terminally Ill Adults (End of Life) Bill, also known as the Assisted Dying Bill, has passed its second reading in the House of Commons.